Page last updated: 2024-08-22
platinum and jm 335
platinum has been researched along with jm 335 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnard, CF; Harrap, KR; Kelland, LR; Mellish, KJ | 1 |
| Cumber-Walsweer, Y; Kelland, LR; O'Neill, CF; Ormerod, MG; Robertson, D; Titley, JC | 1 |
Other Studies
2 other study(ies) available for platinum and jm 335
| Article | Year |
|---|---|
Circumvention of acquired tetraplatin resistance in a human ovarian carcinoma cell line by a novel trans platinum complex, JM335 [trans ammine (cyclohexylamine) dichloro dihydroxo platinum (IV)].
Topics: Antineoplastic Agents; Cadmium; Cadmium Chloride; Chlorides; Cross-Linking Reagents; DNA, Neoplasm; Drug Resistance; Female; Glutathione; Humans; Metallothionein; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Tumor Cells, Cultured | 1994 |
Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Death; DNA, Neoplasm; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Humans; Isomerism; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Time Factors; Tumor Cells, Cultured | 1996 |